FDA Approves First Gene Therapy for Adults with Severe Hemophilia A

FDA Approves First Gene Therapy for Adults with Severe Hemophilia A

FDA U.S. Food & Drug Administration

Image

Please enable the javascript to submit this form

Supported through educational grants from BioMarin, CSL Behring, Pfizer Inc., and Spark Therapeutics

Essential SSL